ArticleJournal of translational medicine2014

MART-1 peptide vaccination plus IMP321 (LAG-3Ig fusion protein) in patients receiving autologous PBMCs after lymphodepletion: results of a Phase I trial.

Emanuela Romano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.